Health care · Updated 18 September 2026 · 9 min read
Pharmaceutical Companies' Employee Compensation
This analysis compares A-share companies classified as Pharmaceuticals in the supplied industry dataset. Medical-device and other health-care service companies classified elsewhere are excluded.
Quick answer
Among 283 A-share pharmaceutical companies, median reported average compensation was CN¥172,683 in 2025, compared with a mean of CN¥199,847.
Companies
283
Pharmaceuticals industry
2025 median
CN¥172,683
Company observations
2025 mean
CN¥199,847
Sensitive to outliers
Business differences among pharmaceutical companies
A research-heavy drug developer and a business with a large manufacturing workforce have different staff mixes. The company table is a starting point for disclosure research, not a ranking adjusted for those business differences.
Top 30 pharmaceutical compensation observations in 2025
Methodology and limitations
- Average compensation is derived from company-reported employee and compensation figures. It is not the salary received by every employee and does not describe individual pay.
- We use the median to reduce the effect of unusually large observations and show the mean as a separate comparison.
- Missing values are excluded. Year-to-year comparisons include only companies with data in both periods.
- This article is factual data analysis. It is not investment advice, a stock recommendation, or an asset-management service.
- The sample includes companies classified as 医药 (Pharmaceuticals) in the supplied industry dataset.